OUTCOMES OF TRANSCATHETER MITRAL VALVE REPAIR IN PATIENTS WITH SECONDARY MITRAL REGURGITATION ACCORDING TO THE SEVERITY OF LEFT VENTRICULAR DYSFUNCTION: THE COAPT TRIAL

In the COAPT trial, transcatheter mitral valve repair with the MitraClip plus guideline directed medical therapy (GDMT) improved clinical outcomes in comparison to GDMT alone in symptomatic patients with heart failure (HF) and 3+ or 4+ secondary mitral regurgitation (SMR) due to LV dysfunction. We